Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of…

Overview of attention for article published in Journal of Clinical Oncology, February 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 13 news outlets
policy: 2 policy sources

twitter: 60 X users
facebook: 2 Facebook pages

Citations

dimensions_citation: 410 Dimensions

Readers on

mendeley: 322 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Vizimpro for Non-Small Cell Lung Cancer – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

The selection and use of essential in vitro diagnostics: report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (‎including the third WHO model list of essential in vitro diagnostics)‎

Cited by World Health Organization on 29 Jan 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

The selection and use of essential in vitro diagnostics: report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (‎including the third WHO model list of essential in vitro diagnostics)‎

Cited by World Health Organization on 01 Jan 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of…

About this Attention Score

Mentioned by

Citations

Readers on

Vizimpro for Non-Small Cell Lung Cancer – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

The selection and use of essential in vitro diagnostics: report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (‎including the third WHO model list of essential in vitro diagnostics)‎

Cited by World Health Organization on 29 Jan 2021

The selection and use of essential in vitro diagnostics: report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (‎including the third WHO model list of essential in vitro diagnostics)‎

Cited by World Health Organization on 01 Jan 2021

Keytruda for Squamous NSCLC – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 06 May 2020